Health

Breakthrough Revealed: How Lecanemab Fights Alzheimer’s Disease

Science Daily

Discover how Lecanemab fights Alzheimer’s by activating brain immune cells. Learn about the groundbreaking research revealing its mechanism of action.

Lecanemab targets amyloid plaques, slowing cognitive decline.

Discover how the Fc fragment activates microglia for plaque clearance.

Over 55 million people are affected by Alzheimer's globally.

This study clarifies Lecanemab's mechanism, paving the way for future therapies.

Read the full article for more details

Read Full Article

Glipzo